Autopsy report · NCT00393224

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“Determined not to be human subject reseach”

The sponsor’s own words in the registry.

Life of this trial

Registered 1 year 4 months after it had already started.
Ran for about 14 years 11 months before it stopped.
952 participants enrolled.
No results are posted on the registry.

Vital statistics

Status: Terminated
Sponsor: National Cancer Institute (NCI)
Sponsor type: US National Institutes of Health
Conditions: Nasopharyngeal Neoplasms
Participants: 952
Sites: 1
Countries: China

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.